(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients.

Ahmedabad: Global lifesciences company, Zydus Lifesciences Limited ... and Southeast Asian regions. Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Dahod Lok Sabha constituency has 9 candidates in the fray. The candidates contesting for the Dahod seat are 9. The assets and liabilities declared by each of the candidates are as follows - Bariya ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

The discussions emphasised the evolving landscape of acute liver failure, sepsis in chronic liver disease, and post-transplant critical care The Tribune, now published from Chandigarh, started ...

This four-year MSci programme offers an outstanding education in the thriving fields of science and medical physics. You will gain a strong foundation in core physics as well as specialist knowledge ...

Bridge the gap between science and medicine on this three-year BSc (Hons) programme. Gain an in-depth understanding of how cutting-edge scientific research leads to improvements in clinical practice ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organisation (WHO), seasonal ...

Zydus Lifesciences on Wednesday (February 26 ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organisation, seasonal influenza results in ...